Insider Transactions Reported by 13 Insiders of Decibel Therapeutics, Inc.

Location
Boston, MA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Decibel Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matthew C. Kapusta Director 25 Sep 2023
James B. Murphy Interim Chief Financial Officer Exhibit Index: 24.1 Power of Attorney 07 Oct 2022
Sara Nochur Director 25 Sep 2023
Elisabeth Leiderman Chief Financial Officer 25 Feb 2022
Peter A. Thompson Director, 10%+ Owner 17 Jun 2022
Cynthia W. Hu General Counsel 16 Aug 2021
William H. Carson Director 25 Sep 2023
Neil Exter Director, 10%+ Owner 17 Jun 2022
Anna Trask Chief People Officer 25 Sep 2023
Alison Cecily Finger Director 25 Sep 2023
John Jui-Jen Lee Chief Development Officer 25 Sep 2023
Kevin F. Mclaughlin Director 25 Sep 2023
Laurence Reid President and Chief Executive Officer, Director 25 Sep 2023

Recent Insider Transactions by Companies or Individuals for Decibel Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.